-
Sensorion Finishes Enrolling Patients in Second Cohort of Its Phase 1/2 Trial for Congenital Deafness Gene Therapy SENS-501
08 Aug 2025 05:01 GMT
… of its phase 1/2 Audiogene clinical trial (NCT06370351) … professionals involved in this clinical trial.”
Sensorion is advancing … in Audiogene phase 1/2 gene therapy clinical trial. News release … . Sensorion receives orphan drug designation for OTOF-GT …
-
Strand raises another $153M to make ‘programmable’ mRNA drugs
08 Aug 2025 07:57 GMT
… STX-003 should start a Phase 1 clinical trial next year, said Jake Becraft … ’s been well-studied by drugmakers as a potential booster to … prove it can deliver its drugs to a variety of organs …
-
"Triple Threat" Car T-Cell Therapy Clinical Trial Debuts at KU Cancer Center
07 Aug 2025 20:43 GMT
… the U.S. Food and Drug Administration (FDA) approved the first … under evaluation via a Phase 1, first-in-human clinical trial initiated by McGuirk … cancer cell,” said McGuirk.
The Phase 1 clinical trial, led by McGuirk, targets three …
-
Cancer Cachexia Clinical Trial Pipeline Shows Potential With Active Contributions From 18+ Key Companies Delveinsight
07 Aug 2025 17:07 GMT
… and Drug Administration (FDA) to conduct clinical trials in … clinical trial application for GFS202A in an open-label, multi-center phase I … @ Cancer Cachexia Clinical Trials Cancer Cachexia Therapeutics … 5. Cancer Cachexia Clinical Trial Therapeutics 6. Cancer …
-
Cancer Cachexia Clinical Trial Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight
07 Aug 2025 17:00 GMT
… and Drug Administration (FDA) to conduct clinical trials in … clinical trial application for GFS202A in an open-label, multi-center phase I … @ Cancer Cachexia Clinical Trials Cancer Cachexia Therapeutics … 5.
Cancer Cachexia Clinical Trial Therapeutics
6.
Cancer …
-
FDA greenlights phase 1 trial of NSD2 inhibitor in mCRPC
07 Aug 2025 14:56 GMT
… the [investigational new drug application] for our … phase 1 STRIKE-001 trial will be operationalized by the Prostate Cancer Clinical Trials … mCRPC) and announces clinical trial collaboration with Bayer … mcrpc-and-announces-clinical-trial-collaboration-with- …
-
ProteinQure Receives Regulatory Clearance to Initiate Phase I Trial for PQ203 in the U.S. and Canada; Granted FDA Fast Track Designation
07 Aug 2025 14:33 GMT
… , a leader in computational protein drug discovery, today announced it has … and Drug Administration (FDA) and Health Canada to initiate a Phase I clinical trial evaluating …
-
Vertigo Pipeline Insight 2025: Novel Drug Classes And Central Mechanism Targets Drive Innovation Delveinsight
08 Aug 2025 01:11 GMT
… early to mid-stage clinical trials. Several pipeline assets are … agents toward mechanism-specific drugs with neuroprotective or … in a Phase 2 clinical trial.
Learn more about the … Pipeline: Early Stage Products (Phase I)
9. Therapeutic Assessment
10. …
-
Ventricular Tachycardia Pipeline Insight 2025: Innovations In Gene Therapy, Ablation Technologies, And Antiarrhythmic Drug Development Delveinsight
08 Aug 2025 01:11 GMT
… early- to mid-stage clinical trials, aiming to address … Ventricular Tachycardia Treatment Analysis: Drug Profile
ARM210: ARMGO …
. Early-stage product (Phase I) along with the details of … Pipeline: Early Stage Products (Phase I)
9. Therapeutic Assessment
10 …
-
Senti Bio Reports Second Quarter 2025 Financial Results and Confirms Next Data Milestone for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) Expected Q4 2025
07 Aug 2025 12:05 GMT
… we recently received Orphan Drug Designation for SENTI-202 … (RP2D) in its ongoing Phase 1 clinical trial of SENTI-202 (NCT06325748) … data from the ongoing Phase 1 clinical trial of SENTI-202; … availability of data from clinical trials, and the timing thereof …
About
© 1995-2025